Tibotec Therapeutics - Division of Ortho Biotech Products, LP — Marysville, California

Public research footprint of Tibotec Therapeutics - Division of Ortho Biotech Products, LP, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Completed

Stopped or withdrawn

Most-studied conditions

Breast Cancer · Lung Cancer · Prostate Cancer · Unspecified Adult Solid Tumor, Protocol Specific

Recently updated registry entries

NCT00309985 — Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With… (Completed)
NCT00070564 — S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With… (Active Not Recruiting)
NCT01309672 — S1014 Abiraterone Acetate in Treating Patients With Prostate Cancer Who Have Undergone… (Completed)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Tibotec Therapeutics - Division of Ortho Biotech Products, LP?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 07, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.